Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1545-1547
Number of pages	3
Journal	Rheumatology International
Volume	41
Issue number	8
Early online date	10 Jun 2021
DOIs	https://doi.org/10.1007/s00296-021-04918-z
Publication status	Published - Aug 2021

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{c25c7f2ea4b540d4b321abdfb8b6f1a8,

title = "Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases: an immunologic perspective",

author = "Javeria Tariq and Latika Gupta",

year = "2021",

month = aug,

doi = "10.1007/s00296-021-04918-z",

language = "English",

volume = "41",

pages = "1545--1547",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer",

number = "8",

}

TY - JOUR

T1 - Safety and efficacy of COVID-19 vaccines in pregnant women with rheumatic diseases

T2 - an immunologic perspective

AU - Tariq, Javeria

AU - Gupta, Latika

PY - 2021/8

Y1 - 2021/8

UR - https://www.scopus.com/pages/publications/85107480500

U2 - 10.1007/s00296-021-04918-z

DO - 10.1007/s00296-021-04918-z

M3 - Letter

C2 - 34110465

AN - SCOPUS:85107480500

SN - 0172-8172

VL - 41

SP - 1545

EP - 1547

JO - Rheumatology International

JF - Rheumatology International

IS - 8

ER -